Real-World Clinical Outcomes and Treatment Patterns in Advanced/Metastatic EGFR-Mutant NSCLC After Progression on First-Line Osimertinib for French Patients
法国患者一线奥希替尼治疗进展后，晚期/转移性EGFR突变型非小细胞肺癌的真实世界临床结果和治疗模式
期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03465-4
Girard, Nicolas; Macouillard, Pauline; Byng, Danalyn; Meng, Jie; Coerts, Friso; Hunter, Shannon; Struebing, Alessandria; Xiong, Yan; Park, Sarah; Haq, M Inaam; Tymejczyk, Olga; Chouaid, Christos; Audigier-Valette, Clarisse; Debieuvre, Didier; Quantin, Xavier; Bosquet, Lise; Pérol, Maurice
